0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

HYPERSENSITIVITY TO SULFATHIAZOLE

Max S. Wien, M.D.
JAMA. 1941;117(21):1806. doi:10.1001/jama.1941.02820470054022.
Text Size: A A A
Published online

ABSTRACT

To the Editor:—  In The Journal, October 18, page 1378, under correspondence, Dr. Merritt H. Stiles calls attention to what he considers an omission in the table appearing in the article by Dr. E. P. Lieberthal and me (Pemphigus Foliaceuslike Eruption Following Use of Sulfanilamide and Sulfapyridine, The Journal, September 6, p. 850). This table, which was presented by Dr. Perrin Long as a summary of the clinical toxic manifestations of sulfanilamide, sulfapyridine and sulfathiazole was, in my estimation, a superlative tabulation of information up to the time the table was presented by Dr. Long before the Pan American Scientific Congress on May 15, 1940. The status of sulfanilamide, its related drugs and their toxic manifestations is still in a state of flux, as revealed by the great number of contributions to the literature listed in recent editions of the Quarterly Cumulative Index dealing with the various phases of the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();